Omeros | OMER - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
Adma Biologics USD 88.82M 13.19M 2025-12
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Cytokinetics USD 19.2M 1.44M 2026-03
Gilead Sciences USD 5.52B 791M 2026-03
Heron Therapeutics USD 29.47M 3.17M 2025-12
Immunic 0 0 2025-03
Insmed USD 256.46M 38.78M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
MacroGenics USD 31.11M 30.14M 2025-12
Omeros USD -33.16M 18.52M 2024-06
Pacira USD 126.64M 15.61M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Rockwell Medical USD 4.55M 1.49M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
United Therapeutics USD 315.5M 286.6M 2025-12
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Xoma 992K 846K 2024-06